John E. Ray
Impact in
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility
- HIV/AIDS drug development and treatment
- Transplantation top 5%
Papers in
-
- HIV/AIDS drug development and treatment 16
- Antifungal resistance and susceptibility 11
- Virology 10
- HIV Research and Treatment 10
- Co-authors
- Andrew J. McLachlan (9 shared papers)Alan E. Timmcke (9 shared papers)Michael J. Dolton (5 shared papers)Richard Osborne Day (10 shared papers)Byron J. Gathright (9 shared papers)Deborah J. E. Marriott (6 shared papers)Garry G. Graham (5 shared papers)John C. Weed (1 shared paper)
- Journals
- Diseases of the Colon & Rectum (26 papers)Therapeutic Drug Monitoring (9 papers)Antimicrobial Agents and Chemotherapy (6 papers)AIDS (3 papers)HIV Clinical Trials (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
John E. Ray
97 papers receiving 4.3k citations
John E. Ray's Hit Papers
Peers
Comparison fields: 5 of 148
- Infectious Diseases 1.2k
- Transplantation 98
- Virology 171
- Oncology 779
- Reproductive Medicine 204
Countries citing papers authored by John E. Ray
This map shows the geographic impact of John E. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Ray more than expected).
Fields of papers citing papers by John E. Ray
This network shows the impact of papers produced by John E. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Ray. The network helps show where John E. Ray may publish in the future.
Co-authors
The 25 scholars most cited alongside John E. Ray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Pharmacokinetics of Metformin Hit paper breakdown → | 2011 | 1059 |
| 2 | 2012 | 257 | |
| 3 | Endometriosis of the bowel. | 1987 | 184 |
| 4 | 1992 | 183 | |
| 5 | 2012 | 169 | |
| 6 | 1993 | 162 | |
| 7 | 2009 | 143 | |
| 8 | 1992 | 139 | |
| 9 | 2012 | 129 | |
| 10 | 2006 | 120 | |
| 11 | 1979 | 102 | |
| 12 | 2014 | 85 | |
| 13 | 2005 | 68 | |
| 14 | 2003 | 60 | |
| 15 | 1989 | 60 | |
| 16 | 1991 | 57 | |
| 17 | 1975 | 56 | |
| 18 | 1976 | 55 | |
| 19 | 2006 | 53 | |
| 20 | 2008 | 49 |
About John E. Ray
John E. Ray is a scholar working on Infectious Diseases, Virology, Surgery, Epidemiology and Analytical Chemistry, having authored 99 papers that have together received 4.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), Antifungal resistance and susceptibility (11 papers), HIV Research and Treatment (10 papers), Diverticular Disease and Complications (9 papers), Gastrointestinal disorders and treatments (8 papers), Colorectal Cancer Surgical Treatments (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Analytical Chemistry and Chromatography (5 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Transplantation (98 citations), Virology (171 citations), Oncology (779 citations) and Reproductive Medicine (204 citations). John E. Ray has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Andrew J. McLachlan, Alan E. Timmcke, Michael J. Dolton, Richard Osborne Day, Byron J. Gathright, Deborah J. E. Marriott, Garry G. Graham, John C. Weed, Kenneth M. Williams and Jerry Richard Greenfield. Their work appears in journals such as Diseases of the Colon & Rectum, Therapeutic Drug Monitoring, Antimicrobial Agents and Chemotherapy, AIDS and HIV Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.